INTELLIVUE X3 867030

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2020-03-16 for INTELLIVUE X3 867030 manufactured by Philips Medical Systems.

Event Text Entries

[186862268] The customer reported a speaker malfunction. A speaker malfunction nop was displayed on the intellivue x3 and no sound was coming from the device. No adverse event involving a patient or user was reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9610816-2020-00090
MDR Report Key9834392
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2020-03-16
Date of Report2020-03-06
Date Mfgr Received2020-03-06
Device Manufacturer Date2019-04-17
Date Added to Maude2020-03-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationBIOMEDICAL ENGINEER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. BETTY HARRIS
Manufacturer StreetHEWLETT-PACKARD STR.2
Manufacturer CityBOEBLINGEN 71034
Manufacturer CountryGM
Manufacturer Postal71034
Manufacturer G1PHILIPS MEDICAL SYSTEMS
Manufacturer Street3000 MINUTEMAN ROAD
Manufacturer CityANDOVER MA 01810
Manufacturer CountryUS
Manufacturer Postal Code01810
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameINTELLIVUE X3
Generic NameMONITOR, PHYSIOLOGICAL, PATIENT(WITH ARRHYTHMIA DETECTION OR ALARMS)
Product CodeMHX
Date Received2020-03-16
Model Number867030
Catalog Number867030
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerPHILIPS MEDICAL SYSTEMS
Manufacturer AddressHEWLETT-PACKARD STR.2 BOEBLINGEN 71034 GM 71034


Patients

Patient NumberTreatmentOutcomeDate
10 2020-03-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.